Compass Therapeutics, Inc.

Q1 2022 13F Holders

Symbol
CMPX
CUSIP
20454B104
Type
Equity
Class
COM
Num filings
35
Total reported value, excl. options
$85.4 M
Manager Report Date Value ($000) Shares Option Type